Skip to main content
Back to News

News From Around the System

UCI Health to test drug for critically ill COVID-19 patients

UCI Health — May 12, 2020

Orange, Calif. — UCI Health is initiating a clinical study of a drug to treat critically ill COVID-19 patients who face a high mortality rate because of acute inflammation that fills their lungs with fluid, a grave condition that even mechanical ventilation cannot improve. Aviptadil, which has a 20-year history…

Tu Foundation gives $2.5 million for COVID-19 patient care, research

UCI Health — May 10, 2020

Irvine, Calif. — A $2.5-million gift from the John and Mary Tu Foundation to the University of California, Irvine is supporting COVID-19-associated patient care at UCI Health and to advance clinical and translational research across the university campus that is focused on new ways to test for and treat the…

Introducing the UC San Diego Return to Learn Program

UC San Diego Health — May 5, 2020

Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.

Introducing the UC San Diego Return to Learn Program

UC San Diego Health — May 5, 2020

Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall

$55M NIH Grant Advances Clinical and Translational Research at UC San Diego

UC San Diego Health — May 4, 2020

The Altman Clinical and Translational Research Institute at University of California San Diego has received a five-year, $54.7 million Clinical and Translational Science Award from the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health.

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts